| Net Cash Provided by (Used in) Operating Activities |
$39,413 |
USD |
96% |
Q1 2025 |
Q1 2025 |
| Net Cash Provided by (Used in) Financing Activities |
$707 |
USD |
-101% |
Q1 2025 |
Q1 2025 |
| Net Cash Provided by (Used in) Investing Activities |
$1,128,532 |
USD |
443% |
Q1 2024 |
Q1 2024 |
| Common Stock, Par or Stated Value Per Share |
0 |
USD/shares |
|
Q1 2024 |
Q1 2024 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
$48,307 |
USD |
-75% |
Q3 2025 |
Q3 2025 |
| Deferred Tax Assets, Valuation Allowance |
$275,047 |
USD |
142% |
Q4 2024 |
FY 2024 |
| Deferred Tax Assets, Gross |
$275,047 |
USD |
142% |
Q4 2024 |
FY 2024 |
| Deferred Tax Assets, Operating Loss Carryforwards |
$227,385 |
USD |
100% |
Q4 2024 |
FY 2024 |
| Preferred Stock, Shares Issued |
0 |
shares |
|
Q3 2025 |
Q3 2025 |
| Preferred Stock, Shares Authorized |
1,000,000 |
shares |
0% |
Q3 2025 |
Q3 2025 |
| Additional Paid in Capital |
$125,394 |
USD |
-94% |
Q3 2025 |
Q3 2025 |
| Preferred Stock, Shares Outstanding |
0 |
shares |
|
Q3 2025 |
Q3 2025 |
| Share-based Payment Arrangement, Expense |
$112,100 |
USD |
|
Q3 2025 |
Q3 2025 |
| Interest Expense |
$1,311 |
USD |
|
Q3 2025 |
Q3 2025 |
| Preferred Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Q3 2025 |
Q3 2025 |